Skip to content
Combined Shape
Created with Sketch.
Page 1
Created with Sketch.
Page 1
Created with Sketch.
COVID-19
EyewireTV
Stocks
Interests
Cataract and Refractive
Eye-Grey
Created with Sketch.
Glaucoma
Gauge-Grey
Created with Sketch.
Healthcare
Cross-Grey
Created with Sketch.
Optometry
Laser-Grey
Created with Sketch.
Product Approvals
Gear-Grey
Created with Sketch.
Retina
Laser-Grey
Created with Sketch.
More
Events
Subscribe
About
Send a Tip
Advertising
Privacy Policy
COVID-19
EyewireTV
Stocks
Interests
Cataract and Refractive
Eye-Grey
Created with Sketch.
Glaucoma
Gauge-Grey
Created with Sketch.
Healthcare
Cross-Grey
Created with Sketch.
Optometry
Laser-Grey
Created with Sketch.
Product Approvals
Gear-Grey
Created with Sketch.
Retina
Laser-Grey
Created with Sketch.
Events
About
Send a Tip
Advertising
Privacy Policy
Page 1
Created with Sketch.
iStent infinite
01.13.21
US IDE Trial Results for Glaukos’ iStent infinite Show Reduction in IOP
Source: Glaukos
10.11.19
Glaukos Achieves Pipeline Milestone with Completion of Patient Enrollment in US IDE Trial for iStent infinite
Source: Glaukos
View more stories
Home
Menu
Share
